Clinical Trials on Carcinoma, Skin Appendage
Total 70903 results
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)WithdrawnSquamous Cell Carcinoma of the Skin | Recurrent Skin Cancer | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity | Stage IVA Squamous Cell Carcinoma of the...United States
-
Boston UniversityRecruitingSuperficial Basal Cell Carcinoma | Squamous Cell Carcinoma in SituUnited States
-
University of California, San FranciscoNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Gangnam Severance HospitalCompleted
-
Rutgers, The State University of New JerseyRutgers Cancer Institute of New Jersey; Elekta Limited; Cianna Medical, Inc.CompletedInvasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Ductal Breast Carcinoma In SituUnited States
-
Centre Hospitalier Universitaire VaudoisRecruitingBasal Cell Carcinoma | Cutaneous Squamous Cell CarcinomaSwitzerland
-
University Hospital TuebingenRecruitingBreast Carcinoma | Breast Carcinoma in SituGermany
-
Liao NingRecruiting
-
Roswell Park Cancer InstituteCompletedInvasive Breast CarcinomaUnited States
-
Qingdao Central HospitalCompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastChina
-
Istituto Scientifico Romagnolo per lo Studio e...CompletedHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastItaly
-
M.D. Anderson Cancer CenterRecruitingRenal Medullary Carcinoma | CarcinomasUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedStage I Breast Cancer | Stage IIIA Breast Cancer | Invasive Breast Carcinoma | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Ductal Breast Carcinoma In SituUnited States
-
Maastricht University Medical CenterNot yet recruitingBasal Cell Carcinoma
-
Tampere University HospitalOlfactomics OyRecruiting
-
H. Lee Moffitt Cancer Center and Research InstituteBoehringer IngelheimRecruitingSquamous Cell CarcinomaUnited States
-
Alpha Tau Medical LTD.CompletedSquamous Cell CarcinomaIsrael
-
Universidad Autonoma de San Luis PotosíHospital Central "Dr. Ignacio Morones Prieto"Unknown
-
Abel Torres, MDCompletedBasal Cell Carcinoma
-
Galderma R&DNo longer availableBasal Cell Carcinoma | Bowen's Disease | Field Actinic Keratoses
-
Ohio State University Comprehensive Cancer CenterCompletedBRCA1 Gene Mutation | BRCA2 Gene Mutation | Ductal Breast Carcinoma in Situ | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in SituUnited States
-
University of WashingtonNational Cancer Institute (NCI); National Institute of Nursing Research (NINR)CompletedDuctal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Atypical Ductal Breast Hyperplasia | Lobular Breast Carcinoma in Situ | Atypical Lobular Breast HyperplasiaUnited States
-
National Cancer Institute (NCI)CompletedPsoriasis | Basal Cell Carcinoma | Keratosis Palmaris et PlantarisUnited States
-
Outcomes4MeMassachusetts General HospitalUnknownBreast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Metastatic Breast CarcinomaUnited States
-
LEO PharmaTerminatedActinic Keratosis | Squamous Cell CarcinomaUnited States, Spain, Canada, Germany, France, United Kingdom
-
Northwestern UniversityCompletedActinic Keratosis | Squamous Cell CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterNot yet recruitingBreast Carcinoma | Breast Atypical Ductal Hyperplasia | Breast Atypical Lobular Hyperplasia | Breast Lobular Carcinoma In Situ | Breast Sclerosing AdenosisUnited States
-
University of Texas Southwestern Medical CenterCompleted
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedStage 0 Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Lobular Breast Carcinoma In Situ | Ductal Breast Carcinoma In Situ | BRCA1 Mutation Carrier | BRCA2 Mutation CarrierUnited States
-
NYU Langone HealthUnited States Department of DefenseCompletedAtypical Ductal Breast Hyperplasia | Lobular Carcinoma in Situ (LCIS) | Atypical Lobular Hyperplasia (ALH) of BreastUnited States
-
St. Joseph Hospital of OrangeActive, not recruitingInvasive Lobular and Ductal CarcinomaUnited States
-
Providence Health & ServicesProvidence Cancer Center, Earle A. Chiles Research Institute; Galecto Biotech... and other collaboratorsRecruitingMetastatic Melanoma | Head and Neck Squamous Cell CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingEdema | Erythema | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Recurrent Inflammatory Breast Carcinoma | Stage IV Inflammatory Breast Carcinoma | Peau d'OrangeUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); California Breast Cancer Research ProgramCompletedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Ductal Breast Carcinoma in Situ | BRCA1 Mutation Carrier | BRCA2 Mutation Carrier | Lobular Breast Carcinoma in SituUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMetastatic Skin Squamous Cell Carcinoma | Metastatic Malignant Neoplasm | Unresectable Malignant Neoplasm | Refractory Malignant Neoplasm | Appendix Adenocarcinoma | Locally Advanced Malignant Neoplasm | Skin Squamous Cell Carcinoma | Locally Advanced Skin Squamous Cell Carcinoma | Metastatic Small... and other conditionsUnited States
-
Ionimed Analytik GmbHMedical University InnsbruckTerminated
-
Institut Cancerologie de l'OuestRecruitingMastectomy | Ductal Carcinoma in Situ | Extensive DiseaseFrance
-
Replimune Inc.Regeneron PharmaceuticalsActive, not recruitingCutaneous Squamous Cell Carcinoma | Advanced Cutaneous Squamous Cell Carcinoma | Metastatic Cutaneous Squamous Cell CarcinomaSpain, United States, France, Australia, Germany, Canada, Greece, Bulgaria, Italy, Poland
-
Jacek CalikRecruitingBasal Cell CarcinomaPoland
-
Skin Care Network Ltd.Completed
-
Institute of Oncology LjubljanaCompleted
-
Daiichi Sankyo, Inc.Bristol-Myers Squibb; AstraZenecaActive, not recruitingBreast Cancer | Urothelial CarcinomaUnited States, Spain, Italy, Belgium, France, Germany, United Kingdom
-
Johns Hopkins UniversityCompleted
-
Novartis PharmaceuticalsCompletedBasal Cell CarcinomaFrance, Italy, Germany, Hungary, United Kingdom, United States, Spain, Belgium, Switzerland, Australia, Canada, Greece
-
Sentara Norfolk General HospitalGeorge Mason University; Dorothy G. Hoefer FoundationCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | HER2/Neu Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
National Cancer Institute (NCI)CompletedRecurrent Breast Carcinoma | Invasive Breast Carcinoma | Estrogen Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
National Cancer Institute (NCI)CompletedMelanoma | Skin Cancer | Basal Cell Carcinoma | Squamous Cell Carcinoma | Xeroderma PigmentosumUnited States
-
University of ZagrebUniversity of RijekaCompletedOral Squamous Cell Carcinoma | Oral Lichen PlanusCroatia
-
SamanTree Medical SASt. Vincenz Krankenhaus GmbH, PaderbornCompletedBreast-Conserving Surgery | Breast Cancer - Ductal Carcinoma in Situ (DCIS)Germany